MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$24,200K
Free Cash flow
-$16,600K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Depreciation and amortization
Inventories
Net income
Others
Negative Cash Flow Breakdown
Accrued expenses
Net loss on asset dispositions
Capital expenditures
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income
5,100
-1,300
-1,400
-70,200
Depreciation and amortization
10,200
9,900
9,400
19,600
Stock-based compensation expense
3,700
1,200
3,500
7,900
Goodwill and intangibles impairment
-
77,000
-
-
Loss on rh disposal
-
0
-
-
Goodwill impairment
-
-
0
77,000
Net losses on asset dispositions and asset impairments
-
-9,300
-
-
Net loss on asset dispositions
5,600
-
-5,400
-300
Accounts receivable
300
-8,100
-700
-22,100
Inventories
-6,100
-2,800
500
2,100
Prepaid expenses and other assets
2,400
-3,000
3,800
-2,200
Accounts payable
-2,100
1,100
1,100
-1,600
Accrued expenses
-33,700
9,500
-400
-22,000
Deferred income taxes and other
1,000
-9,700
0
-700
Cash (used in) provided by operating activities
-12,300
28,200
14,000
32,500
Proceeds from the sale of assets
-
0
4,000
-
Proceeds from the rh divestiture
-
0
0
0
Proceeds from rh divestiture post-closing settlement
-
0
-
-
Capital expenditures
4,300
6,900
7,000
17,700
Acquisition of assets and investments in businesses
-
-
-28,300
-
Acquisition of assets and businesses, net of cash acquired
-
28,000
-
-
Investments in non-affiliates
3,400
200
200
4,600
Cash used in investing activities
-7,700
-6,800
-31,500
-22,300
Secured debt repayments
2,300
2,400
2,300
4,700
Revolving credit facility proceeds
-
0
0
0
Revolving credit facility repayments
0
0
0
25,000
Purchases of treasury stock
1,300
300
0
3,000
Proceeds from the exercise of stock options
400
0
300
400
Payment of contingent consideration liabilities
-
0
0
0
Cash used in financing activities
-3,200
-2,700
-2,000
-32,300
Effect of exchange rate changes on cash and cash equivalents
-1,000
600
-300
4,700
Decrease in cash and cash equivalents
-24,200
19,300
-19,800
-17,400
Cash and cash equivalents - beginning of period
89,800
70,500
107,700
-
Cash and cash equivalents - end of period
65,600
89,800
70,500
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Decrease in cash and cash
equivalents
-$24,200K
Depreciation and
amortization
$10,200K
Inventories
-$6,100K
something is missing
$5,700K
Net income
$5,100K
Stock-based compensation
expense
$3,700K
Deferred income taxes and
other
$1,000K
Proceeds from the
exercise of stock options
$400K
Cash (used in)
provided by operating...
-$12,300K
Cash used in
investing activities
-$7,700K
Cash used in
financing activities
-$3,200K
Effect of exchange rate
changes on cash and cash...
-$1,000K
Canceled cashflow
$31,800K
Canceled cashflow
$400K
Accrued expenses
-$33,700K
Capital expenditures
$4,300K
Investments in
non-affiliates
$3,400K
Secured debt repayments
$2,300K
Purchases of treasury
stock
$1,300K
Net loss on asset
dispositions
$5,600K
Prepaid expenses and
other assets
$2,400K
Accounts payable
-$2,100K
Accounts receivable
$300K
Buy us a coffee
AVANOS MEDICAL, INC. (AVNS)
AVANOS MEDICAL, INC. (AVNS)